Page 6 - Children Bookt.pdf

GUIDELINES FOR THE CLINICAL MANAGEMENT OF HIV INFECTION IN CHILDREN IN MYANMAR

DBS dried blood spot IRIS immune reconstitution
ddI didanosine
%! !
&&
LDH lactate dehydrogenaRT RNA ribonucleic acid
LGE lineal gingival erythema RTI reverse transcriptase inhibitor
LIP lymphocytic interstitial RTV ritonavir
Pneumonia RUTF ready-to-use therapeutic
LPV lopinavir feeds
LTB laryngotracheal bronchitis SD standard deviation
MCH maternal-child health sd-NVP single-dose nevirapine
MDR multidrug resistant SQV saquinavir
MTCT mother-to-child transmission
(of HIV) T20 enfurvirtide
MUAC mid-upper arm circumference TAM thymidine analogue mutation
[
!! !
\ ?
[]*

!:
^]
:

+ !
!
NNRTI non-nucleoside reverse TEN toxic epidermal necrolysis
transcriptase inhibitor TLC total lymphocyte count
NPA nasopharyngeal aspirate TPV tipranavir
NRTI nucleoside reverse TRG Technical Reference Group
transcriptase inhibitor on Paediatric HIV Care and
Treatment
NSAID non-steroidal anti- TST tuberculin skin test

%! !
&
NVP nevirapine ULN upper limit of normal
OI opportunistic infection UNAIDS Joint United Nations
PCP Pneumocystis pneumonia Programme on HIV/AIDS
PCR polymerase chain reaction UNICEF United Nations
Children’s Fund
PENTA Paediatric European Network Up24 Ag ultrasensitive p24 antigen
for Treatment of AIDS
PGL persistent generalized URTI upper respiratory tract
Lymphadenopathy infection
PI protease inhibitor USAID United States Agency for
p.m. post meridiem (denotes International Development
afternoon) WBC white blood cell count
PMTCT prevention of mother-to-child WHO World Health Organization
transmission (of HIV)
/r low-dose ritonavir XD Rextensively drug resistant
RCT randomized controlled trial
RDA recommended daily allowance
REE resting energy expenditure

iv